BLND vs HCAT: stock comparison and AI forecast
Blend Labs, Inc. (BLND) and Health Catalyst, Inc. (HCAT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BLND Blend Labs, Inc.
- Price
- $0.98 -39.3% · 6M
- Market Cap
- $233M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
HCAT Health Catalyst, Inc.
- Market Cap
- $110M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BLND is 2.1 times larger than HCAT by market capitalization ($233M against $110M).
- Both companies share the SEC industry classification Services-Computer Programming, Data Processing, Etc..
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BLND | HCAT |
|---|---|---|
| Market Cap | $233M | $110M |
| P/B Ratio | – | 0.75x |
| EPS | $-0.15 | $-3.78 |
| Book Value/Share | – | $1.93 |
| Revenue/Share | $0.55 | $3.62 |
| FCF/Share | $0.06 | $0.34 |
Profitability & Margins
| Metric | BLND | HCAT |
|---|---|---|
| ROE | – | -138.8% |
| ROA | – | -85.1% |
| ROIC | -13.8% | -112.3% |
| Gross Margin | 74.2% | 49.1% |
| Operating Margin | -10.6% | -65.7% |
| Net Margin | – | -74.2% |
| EBT Margin | -9.1% | -79.2% |
| Tax Rate | -3.7% | -0.3% |
Financial Health
| Metric | BLND | HCAT |
|---|---|---|
| Current Ratio | 1.72x | 1.70x |
| D/E Ratio | – | 0.63x |
| Financial Leverage | – | 1.63x |
| Interest Coverage | 3.0x | -3.9x |
| Working Capital | $32M | $55M |
Cash Flow
| Metric | BLND | HCAT |
|---|---|---|
| Operating Cash Flow | $17M | $27M |
| Free Cash Flow | $13M | $26M |
| Capital Spending | -$4M | -$1M |
| OCF Growth YoY | 188.0% | – |
| FCF/Sales | 10.3% | 9.4% |
| CapEx/Sales | 2.9% | 0.4% |
Operational Efficiency
| Metric | BLND | HCAT |
|---|---|---|
| Asset Turnover | 0.90x | 1.15x |
| Receivables Turnover | – | 6.6x |
| Fixed Assets Turnover | 6.1x | 7.9x |
| Days Sales Outstanding | – | 55 days |
| Payables Period | 14 days | 17 days |
Income Statement
| Metric | BLND | HCAT |
|---|---|---|
| Total Revenue | $130M | $272M |
| Operating Income | -$14M | -$179M |
| Net Income | – | -$202M |
| R&D Expense | $36M | $40M |
| SG&A Expense | $122M | $105M |
| Cost of Goods Sold | $34M | $138M |
Dividend & Shareholder Information
| Metric | BLND | HCAT |
|---|---|---|
| Shares Outstanding | 237M | 75M |
BLND vs HCAT: stock comparison and AI forecast
Which is bigger, BLND or HCAT?
BLND is 2.1 times larger than HCAT by market capitalization ($233M against $110M).
Which one does Intratio's AI model rank higher, BLND or HCAT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.